FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C-myc

FEBS Letters

Volumn 587, Issue 14, 2013, Pages 2105-2111

  Qinyu, Li ^a   Long, Cui ^a   Zhen Dong, Du ^b   Min Min, Shi ^a   Wei Ze, Wu ^a   Wei Ping, Yang ^a   Cheng Hong, Peng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C myc; Cell proliferation; FOXO6; Gastric cancer; HNF4

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4; MESSENGER RNA; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO6; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION;

ACETYLATION; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE DEACETYLASES; HISTONES; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84879688838     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.05.027     Document Type: Article

References (33)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J. Clin. 55 2005 74 108
2. A. Cervantes, D. Roda, N. Tarazona, S. Rosello, and J.A. Perez-Fidalgo Current questions for the treatment of advanced gastric cancer Cancer Treat. Rev. 39 2013 60 67
3. G. Tamura Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer World J. Gastroenterol. 12 2006 192 198
4. Y. Asaoka, T. Ikenoue, and K. Koike New targeted therapies for gastric cancer Expert Opin. Investig. Drugs 20 2011 595 604
5. K. Almhanna, J. Strosberg, and M. Malafa Targeting AKT protein kinase in gastric cancer Anticancer Res. 31 2011 4387 4392
6. D. Weigel, G. Jurgens, F. Kuttner, E. Seifert, and H. Jackle The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo Cell 57 1989 645 658
7. E.L. Greer, and A. Brunet FOXO transcription factors at the interface between longevity and tumor suppression Oncogene 24 2005 7410 7425
8. D.E. Kloet, and B.M. Burgering The PKB/FOXO switch in aging and cancer Biochim. Biophys. Acta 1813 2011 1926 1937
9. J.H. Kim Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer Mod. Pathol. 20 2007 835 842
10. R.H. Medema, G.J. Kops, J.L. Bos, and B.M. Burgering AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 Nature 404 2000 782 787
11. M. Schmidt, S. Fernandez de Mattos, A. van der Horst, R. Klompmaker, G.J. Kops, E.W. Lam, B.M. Burgering, and R.H. Medema Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D Mol. Cell. Biol. 22 2002 7842 7852
12. G.J. Kops, R.H. Medema, J. Glassford, M.A. Essers, P.F. Dijkers, P.J. Coffer, E.W. Lam, and B.M. Burgering Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors Mol. Cell. Biol. 22 2002 2025 2036
13. D.H. Kim FoxO6 integrates insulin signaling with gluconeogenesis in the liver Diabetes 60 2011 2763 2774
14. D.A. Salih FoxO6 regulates memory consolidation and synaptic function Genes Dev. 26 2012 2780 2801
15. A. Cascon, and M. Robledo MAX and MYC: a heritable breakup Cancer Res. 72 2012 3119 3124
16. J. Secombe, S.B. Pierce, and R.N. Eisenman Myc: a weapon of mass destruction Cell 117 2004 153 156
17. D.M. Lonard, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators and human disease Endocr. Rev. 28 2007 575 587
18. Y.B. Xie, B. Nedumaran, and H.S. Choi Molecular characterization of SMILE as a novel corepressor of nuclear receptors Nucleic Acids Res. 37 2009 4100 4115
19. B. Guillemette H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation PLoS Genet. 7 2011 e1001354
20. J. Krejci, R. Uhlirova, G. Galiova, S. Kozubek, J. Smigova, and E. Bartova Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation J. Cell. Physiol. 219 2009 677 687
21. D.B. Zimonjic, and N.C. Popescu Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review) Int. J. Oncol. 41 2012 393 406
22. C.V. Dang MYC on the path to cancer Cell 149 2012 22 35
23. S. Cairo, C. Armengol, and M.A. Buendia Activation of Wnt and Myc signaling in hepatoblastoma Front. Biosci. (Elite Ed) 4 2012 480 486
24. X. Liu, H. Cai, H. Huang, Z. Long, Y. Shi, and Y. Wang The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients PLoS One 6 2011 e29670
25. J. Luo, Y.N. Li, F. Wang, W.M. Zhang, and X. Geng S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer Int. J. Biol. Sci. 6 2010 784 795
26. D.Z. Xu Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer BMC Cancer 10 2010 536
27. Y. Zhao Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity Nat. Cell Biol. 12 2010 665 675
28. W. Zhong, F.M. Sladek, and J.E. Darnell Jr. The expression pattern of a Drosophila homolog to the mouse transcription factor HNF-4 suggests a determinative role in gut formation EMBO J. 12 1993 537 544
29. F. Parviz Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis Nat. Genet. 34 2003 292 296
30. R.K. Gupta, and K.H. Kaestner HNF-4alpha: from MODY to late-onset type 2 diabetes Trends Mol. Med. 10 2004 521 524
31. L. Xu Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma Cancer Res. 61 2001 3176 3181
32. C. Yin Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene Hepatology 48 2008 1528 1539
33. M. Darsigny, J.P. Babeu, E.G. Seidman, F.P. Gendron, E. Levy, J. Carrier, N. Perreault, and F. Boudreau Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species Cancer Res. 70 2010 9423 9433